TrialCephalalgia : an international journal of headache2019

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN.

John H Krege et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.